Our Chief Medical and Scientific Advisor, Dr John Krakauer, recently joined ‘Chatter’ podcast host Josh Hamilton to d...
Neurotherapeutics devices company MindMaze Healthcare has announced its commercial product portfolio and clinical pip...
In 2020, CTA launched a new initiative to develop standards for the use of digital therapeutics — an emerging field t...
Bringing the future of brain repair for stroke, Parkinson’s, and other neurological conditions to patients in&n...
What’s better than one new partnership expanding the global reach of MindMaze’s neurotherapeutic platform? Simple: Fo...
MindMaze creates gamified digital neurotherapeutics for patients with neurological injuries and conditions such as st...
LAUSANNE, Switzerland, April 15, 2021 – MindMaze Healthcare (MMHC), a global pioneer in the multibillion-dollar...
Video: MindMaze Head of Neuro Science, Dr. Andrea Serino, recently took part in Aging 2.0’s ‘Agetech’ webinar, ...